Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient

Sunitinib, a multitargeted tyrosine Kkinase inhibitor (TKI), is currently the standard of care for patients with metastatic renal cell carcinoma. Renal adverse events associated with sunitinib include proteinuria, renal insufficiency secondary to focal segmental glomerulosclerosis (FSGS), and thromb...

Full description

Bibliographic Details
Main Authors: Ibrahim Azar, Saghi Esfandiarifard, Pedram Sinai, Ali Wazir, Llewellyn Foulke, Syed Mehdi
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2017/6328204

Similar Items